Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Spero Therapeutics (SPRO) Asset Utilization Ratio (2017 - 2025)

Spero Therapeutics (SPRO) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.57 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 352.41% year-over-year to 0.57, compared with a TTM value of 0.57 through Sep 2025, up 352.41%, and an annual FY2024 reading of 0.18, up 2937.57% over the prior year.
  • Asset Utilization Ratio was 0.57 for Q3 2025 at Spero Therapeutics, down from 0.59 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.59 in Q2 2025 and bottomed at 0.01 in Q1 2024.
  • Average Asset Utilization Ratio over 5 years is 0.19, with a median of 0.18 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio crashed 103.24% in 2024, then surged 6216.67% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.18 in 2021, then grew by 10.84% to 0.2 in 2022, then tumbled by 96.79% to 0.01 in 2023, then surged by 3312.77% to 0.22 in 2024, then soared by 158.14% to 0.57 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SPRO at 0.57 in Q3 2025, 0.59 in Q2 2025, and 0.35 in Q1 2025.